Ovid Therapeutics (OVID) Short-term Investments (2018 - 2026)
Ovid Therapeutics (OVID) reported Short-term Investments of $105.89 million for Q2 2026, up 966.2% from $9.93 million a year earlier and up 72.3% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Short-term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Ovid Therapeutics posted Short-term Investments of $56.48 million, up 111.0% from FY2024.
- Short-term Investments has a three-year compound annual growth rate of -12.4% (FY2022 to FY2025).
- By year, Short-term Investments came in at $26.77 million in FY2024 (-66.0%), $78.79 million in FY2023 (-6.3%) and $84.13 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Short-term Investments in data going back to Q1 2018.
- Year over year, Short-term Investments has now increased in each of the last three quarters, with growth averaging 127.7% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was Q2 2026 (growth of 966.2%); the low point was Q3 2025 (a decline of 89.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $61.46 million (Q1 2026), $56.48 million (Q4 2025) and $4.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.89 Mn |
| Mar 31, 2026 | 61.46 Mn |
| Dec 31, 2025 | 56.48 Mn |
| Sep 30, 2025 | 4.99 Mn |
| Jun 30, 2025 | 9.93 Mn |
| Mar 31, 2025 | 21.86 Mn |
| Dec 31, 2024 | 26.77 Mn |
| Sep 30, 2024 | 47.70 Mn |
| Jun 30, 2024 | 47.28 Mn |
| Mar 31, 2024 | 59.49 Mn |
| Dec 31, 2023 | 78.79 Mn |
| Sep 30, 2023 | 29.64 Mn |
| Jun 30, 2023 | 24.89 Mn |
| Mar 31, 2023 | 54.67 Mn |
| Dec 31, 2022 | 84.13 Mn |
| Sep 30, 2022 | 79.60 Mn |
| Jun 30, 2022 | 79.55 Mn |
| Mar 31, 2020 | 31.00 Mn |
| Dec 31, 2019 | 34.84 Mn |
| Mar 31, 2019 | 5.04 Mn |
API Access
Ovid Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();